
Delpizin M 10mg/1000mg Tablet SR
Marketer
Uniza Healthcare LLP
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg)
Overview Delpizin M 10mg/1000mg Tablet SR
Combiprel D 10mg/1000mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This dual-action formulation regulates elevated blood glucose, lessening the risk of severe diabetic complications, including cardiovascular issues. Combiprel D can be administered with meals, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation to avoid elevated blood sugar and potential complications such as renal impairment and vision loss. This medication complements a comprehensive diabetes management plan encompassing dietary adjustments, physical activity, and weight control, as guided by your doctor. Common side effects may include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration minimizes dehydration risk. Genital fungal infections are a possibility; good hygiene is preventative. Prior to commencing treatment, disclose any kidney or liver disease, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption as it may exacerbate side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Delpizin M 10mg/1000mg Tablet SR
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Delpizin M 10mg/1000mg Tablet SR
Managing type 2 diabetes
Major Benefits of Delpizin M 10mg/1000mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Delpizin M 10mg/1000mg Tablet SR whole; do not chew, crush, or divide it. Administer this extended-release tablet with a meal.
Common Side effects of Delpizin M 10mg/1000mg Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Delpizin M 10mg/1000mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Delpizin M 10mg/1000mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Delpizin M 10mg/1000mg Tablet SR works:
Dapagliflozin/Metformin 10mg/1000mg Extended-Release tablets (Delpizin M) combine two distinct antidiabetic agents to enhance blood glucose management. Dapagliflozin facilitates glucose excretion via the kidneys, while Metformin reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. This dual action promotes superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Delpizin M 10mg/1000mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Delpizin M 10mg/1000mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Delpizin M 10mg/1000mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Delpizin M 10mg/1000mg sustained-release tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Delpizin M 10mg/1000mg sustained-release tablets. Dosage modification of Delpizin M 10mg/1000mg sustained-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Delpizin M 10mg/1000mg Tablet SR :
Should you forget to take a Delpizin M 10mg/1000mg sustained-release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Delpizin M 10mg/1000mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
